J Food Sci February 2017 PMID 28140467

A Survey of Commercially Available Isomaltooligosaccharide-Based Food Ingredients.

Lee R Madsen, Sarah Stanley, Peter Swann, Jack Oswald

Mentions

5
Peak: 2 in Jun 2025
across 3 sources since Feb 2025

Extended reach

37,777
potential audience

Total likes

983

Video views

12,363

Mentions per month

Feb 2025 – Jun 2025

Where it's discussed

  • YouTube2 videos
  • News2 articles
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions highlight concerns about label accuracy and health impacts, with some posts questioning if the findings will influence product labeling standards, while others discuss the digestibility of IMO ingredients, reflecting a nuanced interest and engagement level that balances curiosity with skepticism.

AgreementNeither agree nor disagree

The posts exhibit mixed opinions, with some questioning the findings and others accepting them, leading to a neutral overall stance.

InterestModerate interest

There is moderate interest, as posts reference the relevance of IMO ingredients in food products and their health implications.

EngagementModerate engagement

Discussions delve into technical aspects like digestibility and label accuracy, indicating a moderate level of engagement.

ImpactNeutral impact

The overall impact appears limited to scientific and consumer awareness, without clear indication of broad societal change.

Abstract in brief

  • The text discusses how isomaltooligosaccharides (IMOs), used as high fiber and low-calorie sweeteners, are found in various food products like protein bars and dietary supplements.
  • It describes the methods used to analyze seven commercial IMO ingredients, which are made through bacterial fermentation or transglycosylation of starch, to compare their composition.
  • The findings suggest that the actual digestibility and glycemic impact of these IMO ingredients may not match their label claims, making them unsuitable for diabetics and low-carb diet followers.]

Top posts

Most liked on X and Bluesky
Alexey Weiss, MD
@dweisa · X

@allnovikova1 https://t.co/EFTLJNgd6h

Feb 5, 2025 · 25,415 followers View post →

All mentions

Alexey Weiss, MD
@dweisa · X

@allnovikova1 https://t.co/EFTLJNgd6h

Feb 5, 2025 · 25,415 followers View post →